POET Technologies: A $400 Million Production Bet Entangled in a Web of Lawsuits
11.06.2026 - 17:15:46 | boerse-global.de
POET Technologies has become a study in extremes. The stock has surged 174 percent over the past twelve months, yet it sits nearly 47 percent below its 52-week high of €18.84, and a seven-day slide erased roughly a quarter of its market value. On the latest session, shares bounced 3.55 percent to €9.91, a move that looks more like a stabilisation attempt than a definitive turnaround. The real drama, however, is unfolding in the courtroom and on the factory floor.
Three separate class-action lawsuits have been filed against the company, with a critical deadline of June 29 for investors seeking to act as lead plaintiffs. The complaints centre on two allegations. First, POET is accused of downplaying the risk that it could be classified as a Passive Foreign Investment Company (PFIC), a designation that would impose onerous tax consequences for US shareholders. Second, board member Thomas Mika is said to have disclosed confidential business details in a public interview, allegedly breaching a non?disclosure agreement. That disclosure, the suits claim, prompted Celestial AI — POET’s largest customer, operating through Marvell Semiconductor — to cancel all outstanding orders. The stock subsequently plunged about 47 percent.
The legal cloud arrives at a moment when POET is racing to transform from a speculative photonics story into a volume manufacturer. In May 2026, the company completed a $400 million capital raise, issuing roughly 19 million shares at $21 each, together with a three?year warrant exercisable at $26.25. The proceeds are earmarked for wafer production capacity, R&D, and targeted acquisitions. POET aims to expand its assembly and wafer?fabrication capacity roughly tenfold by 2027. It currently employs more than 115 people, operates an expanded site in Singapore, and maintains 20,000 square feet of assembly space in Malaysia.
Should investors sell immediately? Or is it worth buying POET Technologies?
But the revenue base remains thin. First?quarter 2026 sales reached just $503,000 — a sharp increase from the year?ago period, yet negligible relative to the company’s ambitions. The net loss stood at $12.3 million, and operating cash flow was negative $8.8 million. On the plus side, the balance sheet is nearly debt?free, with a liquidity ratio above 35, and the capital raise provides ample runway. There is no imminent solvency risk.
One bright spot is a strategic supply and development agreement with Lumilens, focused on photonic integration for AI networks. Lumilens placed an initial order worth $50 million, with the potential for cumulative purchases of up to $500 million over five years. That deal offers a tangible offset to the loss of the Celestial AI/Marvell relationship, but it remains to be seen whether other partners will stay the course amid the legal uncertainty.
Technically, the stock is trading just above its 50?day moving average of €9.38, while the relative strength index sits at 46.6 — neutral territory. The 30?day annualised volatility exceeds 212 percent, underscoring the extreme swings that have become routine in the AI?photonics space. For now, the rebound looks like a pause rather than a reversal. The coming quarters will determine whether POET can convert its ambitious production plans and the Lumilens deal into repeatable revenue growth — or whether the legal and operational headwinds prove too strong.
Ad
POET Technologies Stock: New Analysis - 11 June
Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
